Status:
COMPLETED
Retrospective Study of Implants With Peri-implantitis Surgically Treated Using Enamel Matrix Derivative (EMD)
Lead Sponsor:
North Dallas Dental Health
Conditions:
Determination of Beneficial Effect of Using Enamel Matrix Derivative During Implant Treatment
Eligibility:
All Genders
18-90 years
Brief Summary
The existing records of a private practice limited to the practice of periodontology were reviewed to locate patients who had been diagnosed with peri-implantitis (failing dental implant) and had been...
Detailed Description
See brief summary.
Eligibility Criteria
Inclusion
- all adult patients of record who presented with existing peri-implantitis that was clinically deemed treatable (the implant was not considered hopeless.)
Exclusion
- none except for routine medical contraindications for periodontal surgery
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 6 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT05419102
Start Date
April 1 2022
End Date
June 6 2022
Last Update
June 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
North Dallas Dental Health
Dallas, Texas, United States, 75221